Goodwill and Other Intangible Assets

9 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

4. Goodwill and Other Intangible Assets

Goodwill

The following is a summary of goodwill activity for the nine months ended December 31, 2014:

Balance, beginning of period	$	494,700
Acquisition of AKM		84,993
Acquisition of SCHC		161,559
Acquisition of BCHC		542,577
Acquisition of HCHHA		102,651
Balance, end of period	$	1,386,480

Other Intangible Assets

Other intangible assets consisted of the following:

	Weighted-average		Balance at				Balance at
		life	March 31,				December 31,
		(Yrs.)	2014		Additions		2014
Indefinite-lived assets:
Medicare license			$	-	$	704,000	$	704,000

Amortized intangible assets:
Exclusivity		4.0		40,000		-		40,000
Non-compete		4.0		28,400		143,000		171,400
Payor relationships		5.0		-		94,000		94,000
Network relationships		5.0		-		910,000		910,000
Trade name		5.0		-		242,000		242,000
Totals				68,400		2,093,000		2,161,400

Accumulated amortization				(8,773)		(240,795)		(249,568)

Total other intangibles, net			$	59,627	$	1,852,205	$	1,911,832

The amortization expense for the three and nine months ended December 31, 2014 was approximately $110,000 and $241,000, respectively. The amortization expense for the three and nine months ended December 31, 2013 was approximately $1,000 in each period.

Future amortization expense is estimated to be as follows for the period from January 1, 2015 to March 31, 2015 and for each for the five years ending March 31 thereafter:

January 1, 2015 to March 31, 2015	$	112,000
2016	$	447,000
2017	$	445,000
2018	$	87,000
2019	$	63,000
Thereafter	$	54,000

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details